Screener / SEC EDGAR /CIK 0000785161 /10-K filed Feb 26, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Hospitals

Encompass Health Corp EHC

Compare with peers Embed
Earnings releases

Latest results release: Oct 28, 2026

8-K item 2.02, exhibit 99

What EHC's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

In its release of Aug 5, 2026, EHC reported $1.55 per share under GAAP and $1.55 on its own adjusted basis: the adjusted number is +0% above GAAP.

GAAP EPS $1.11, release Apr 24, 2024: Q1 2024 2023 Diluted earnings per share, as reported $ 1.11 $ 0.88 Adjustments, net of tax: Asset i Adjusted EPS $1.12, release Apr 24, 2024: $ 1.11 $ 0.88 Adjustments, net of tax: Asset impairment impact(2) 0.02 — Income tax adjustments (0.01) — Adjusted earnings per share* $ 1.12 $ 0.88 u Adjusted earnings per share re +1% 2024-04 GAAP EPS $1.13, release Aug 5, 2024: Q2 6 Months 2024 2023 2024 2023 Diluted earnings per share, as reported $ 1.13 $ 0.91 $ 2.24 $ 1.79 Adjustments, net o Adjusted EPS $1.11, release Aug 5, 2024: — State regulatory change impact(3) — 0.03 — 0.03 Change in fair market value of equity securities — 0.01 — — Adjusted earnings per share* $ 1.11 $ 0.95 $ 2.23 $ 1.83 u Adjusted earning -2% 2024-08 GAAP EPS $1.07, release Oct 28, 2024: Q3 9 Months 2024 2023 2024 2023 Diluted earnings per share, as reported $ 1.07 $ 0.85 $ 3.31 $ 2.65 Adjustments, net o Adjusted EPS $1.03, release Oct 28, 2024: regulatory change impact(2) — — — 0.03 Change in fair market value of equity securities (0.02) 0.01 (0.02) 0.02 Adjusted earnings per share* $ 1.03 $ 0.86 $ 3.26 $ 2.69 u Adjusted earning -4% 2024-10 GAAP EPS $1.18, release Feb 6, 2025: Q4 Year Ended 2024 2023 2024 2023 Diluted earnings per share, as reported $ 1.18 $ 0.94 $ 4.49 $ 3.59 Adjustments, net o Adjusted EPS $1.17, release Feb 6, 2025: regulatory change impact(4) — — — 0.03 Change in fair market value of equity securities 0.01 (0.02) (0.01) — Adjusted earnings per share* $ 1.17 $ 0.95 $ 4.43 $ 3.64 u Adjusted earning -1% 2025-02 GAAP EPS $1.48, release Apr 24, 2025: Q1 2025 2024 Diluted earnings per share, as reported $ 1.48 $ 1.11 Adjustments, net of tax: Asset i Adjusted EPS $1.37, release Apr 24, 2025: 1.48 $ 1.11 Adjustments, net of tax: Asset impairment impact(3) — 0.02 Income tax adjustments(5) (0.12) (0.01) Adjusted earnings per share* $ 1.37 $ 1.12 u Adjusted earnings per share re -7% 2025-04 GAAP EPS $1.40, release Aug 4, 2025: Q2 6 Months 2025 2024 2025 2024 Diluted earnings per share, as reported $ 1.40 $ 1.13 $ 2.88 $ 2.24 Adjustments, net o Adjusted EPS $1.40, release Aug 4, 2025: Income tax adjustments(5) — (0.02) (0.11) (0.03) Change in fair market value of equity securities — — (0.01) — Adjusted earnings per share* $ 1.40 $ 1.11 $ 2.77 $ 2.23 u Adjusted earning +0% 2025-08 GAAP EPS $1.24, release Oct 29, 2025: Q3 9 Months 2025 2024 2025 2024 Diluted earnings per share, as reported $ 1.24 $ 1.07 $ 4.13 $ 3.31 Adjustments, net o Adjusted EPS $1.23, release Oct 29, 2025: — (0.02) (0.12) (0.05) Change in fair market value of marketable securities (0.01) (0.02) (0.01) (0.02) Adjusted earnings per share* $ 1.23 $ 1.03 $ 3.99 $ 3.26 u Adjusted earning -1% 2025-10 GAAP EPS $1.42, release Feb 5, 2026: Q4 Year Ended 2025 2024 2025 2024 Diluted earnings per share, as reported $ 1.42 $ 1.18 $ 5.55 $ 4.49 Adjustments, net o Adjusted EPS $1.46, release Feb 5, 2026: 0.04 (0.03) (0.08) (0.08) Change in fair market value of marketable securities — 0.01 (0.02) (0.01) Adjusted earnings per share* $ 1.46 $ 1.17 $ 5.45 $ 4.43 u Adjusted earning +3% 2026-02 GAAP EPS $1.77, release Apr 30, 2026: Q1 2026 2025 Diluted earnings per share, as reported $ 1.77 $ 1.48 Adjustments, net of tax: Income Adjusted EPS $1.60, release Apr 30, 2026: $ 1.77 $ 1.48 Adjustments, net of tax: Income tax adjustments(6) (0.05) (0.12) Gain on sale(4) (0.13) — Adjusted earnings per share* $ 1.60 $ 1.37 u Adjusted earnings per share re -10% 2026-04 GAAP EPS $1.55, release Aug 5, 2026: Q2 6 Months 2026 2025 2026 2025 Diluted earnings per share, as reported $ 1.55 $ 1.40 $ 3.32 $ 2.88 Adjustments, net o Adjusted EPS $1.55, release Aug 5, 2026: 0.02 — Change in fair market value of marketable securities (0.02) — (0.02) (0.01) Gain on sale(4) — — (0.13) — Adjusted earnings per share* $ 1.55 $ 1.40 $ 3.15 $ 2.77 u Adjusted earning +0% 2026-08
GAAP EPSAdjusted EPS, as the company defines itThe figure on top is how far adjusted is from GAAP. Click a bar for the sentence.
The company's words, latest release
Q2 6 Months 2026 2025 2026 2025 Diluted earnings per share, as reported $ 1.55 $ 1.40 $ 3.32 $ 2.88 Adjustments, net o release
0.02 — Change in fair market value of marketable securities (0.02) — (0.02) (0.01) Gain on sale(4) — — (0.13) — Adjusted earnings per share* $ 1.55 $ 1.40 $ 3.15 $ 2.77 u Adjusted earning release

What the company says its adjusted numbers leave out:

Adjusted earnings per share should not be considered as a measure of financial performance under generally accepted accounting principles in the United States as the items excluded from it are significant components in understanding and assessing financial performance. release Oct 28, 2026

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Oct 28, 2026 · EX-99.1

Media Contact October 28, 2026

Open on SEC

Media Contact October 28, 2026 ────────────────────────────────────────────────────── Polly Manuel, 205 969-4532 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected]

BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the third quarter ended September 30, 2026.

See attached supplemental information for calculations of non-GAAP measures and reconciliations to their most comparable GAAP measure.

“We are very pleased with our performance for the third quarter, with revenue increasing 8.9% and Adjusted EBITDA growing 15.5%,” said Mark Tarr, President and Chief Executive Officer. “During the first nine months of 2026, we opened four hospitals totaling 189 beds and added 85 beds to existing hospitals, reflecting our commitment to meeting the growing demand for high-quality inpatient rehabilitation services. Our value proposition and disciplined operating strategy continue to be validated, and we remain highly optimistic about the long-term prospects of our business.”

Full-Year 2026 Guidance Previous Guidance Updated Guidance -In Millions, Except Per Share Data Net operating revenue $6,410 to $6,490 $6,450 to $6,500 Adjusted EBITDA $1,365 to $1,395 $1,395 to $1,415 Adjusted earnings per share from continuing operations $6.02 to $6.25 $6.23 to $6.37 attributable to Encompass Health

For considerations regarding the Company’s 2026 guidance, see the supplemental information posted on the Company’s website at http://investor.encompasshealth.com. See also the “Other information” section below for an explanation of why the Company does not provide guidance for comparable GAAP measures for Adjusted EBITDA and adjusted earnings per share.

The Company will host an investor conference call at 10:00 a.m. Eastern Time on Thursday, October 29, 2026 to discuss its results for the third quarter of 2026. For reference during the call, the Company will post certain supplemental information at http://investor.encompasshealth.com.

The conference call may be accessed by dialing 833 354-6854 and giving the conference ID EHCQ326. International callers should dial 785 838-9343 and give the same conference ID. Please call approximately ten minutes before the start of the call to ensure you are connected. The conference call will also be webcast live and will be available for on-line replay at http://investor.encompasshealth.com by clicking on an available link.

Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 179 hospitals in 39 states and Puerto Rico, the Company provides high- quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized by Newsweek as America’s Most Awarded Leader in Inpatient Rehabilitation and is ranked among Fortune's World’s Most Admired Companies™ 1 and Forbes’ America’s Best Companies. It is also recognized by Becker’s Healthcare and Modern Healthcare as a top healthcare employer. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.

1 From Fortune. © 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World’s Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.

The information in this press release is summarized and should be read in conjunction with the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 (the “September 2026 Form 10-Q”), when filed, as well as the Company’s Current Report on Form 8-K filed on October 28, 2026 (the “Q3 Earnings Form 8-K”), to which this press release is attached as Exhibit 99.1. In addition, the Company will post supplemental information today on its website at http://investor.encompasshealth.com for reference during its October 29, 2026 earnings call.

The financial data contained in the press release and supplemental information include non-GAAP financial measures, including the Company’s adjusted earnings per share, leverage ratio, Adjusted EBITDA, and adjusted free cash flow. Reconciliations to their most comparable GAAP measure, except with regard to non-GAAP guidance, are included below or in the Q3 Earnings Form 8-K. Readers are encouraged to review the “Note Regarding Presentation of Non-GAAP Financial Measures” included in the Q3 Earnings Form 8-K which provides further explanation and disclosure regarding the Company’s use of these non-GAAP financial measures.

Excluding net operating revenues, the Company does not provide guidance on a GAAP basis because it is unable to predict, with reasonable certainty, the future impact of items that are deemed to be outside the control of the Company or otherwise not indicative of its ongoing operating performance. Such items include government, class action, and related settlements; professional fees—accounting, tax, and legal; mark-to-market adjustments for stock appreciation rights; gains or losses related to hedging instruments; loss on early extinguishment of debt; adjustments to its income tax provision (such as valuation allowance adjustments and settlements of income tax claims); items related to corporate and facility restructurings; and certain other items the Company believes to be not indicative of its ongoing operations. These items cannot be reasonably predicted and will depend on several factors, including industry and market conditions, and could be material to the Company’s results computed in accordance with GAAP.

However, the following reasonably estimable GAAP measures for 2026 would be included in a reconciliation for Adjusted EBITDA if the other reconciling GAAP measures could be reasonably predicted:

• Interest expense and amortization of debt discounts and fees - approximately $130 million

The Q3 Earnings Form 8-K and, when filed, the September 2026 Form 10-Q can be found on the Company’s website at http://investor.encompasshealth.com and the SEC's website at www.sec.gov.

September 30, 2026 December 31, 2025 ────────────────────────────────────────────────────────────────────────────── -In Millions Assets Current assets: Cash and cash $ 76.2 $ 72.2 equivalents Restricted cash 24.0 30.7 Accounts 712.0 619.2 receivable Other current 200.8 183.8 assets Total current 1,013.0 905.9 assets Property and 4,477.6 4,101.6 equipment, net Operating lease right-of-use 194.5 212.6 assets Goodwill 1,323.5 1,317.6 Intangible 301.5 308.3 assets, net Other long-term 256.4 243.7 assets Total assets $ 7,566.5 $ 7,089.7 Liabilities and Shareholders’ Equity Current liabilities: Current portion of long-term $ 47.8 $ 43.6 debt Current operating lease 28.0 26.5 liabilities Accounts payable 231.4 178.2 Accrued expenses and other 620.2 588.1 current liabilities Total current 927.4 836.4 liabilities Long-term debt, net of current 2,551.3 2,447.2 portion Long-term operating lease 176.3 196.6 liabilities Deferred income 127.5 126.8 tax liabilities Other long-term 222.8 206.9 liabilities Total 4,005.3 3,813.9 liabilities Commitments and contingencies Redeemable noncontrolling 58.6 58.3 interests Shareholders’ equity: Encompass Health shareholders’ 2,681.2 2,438.2 equity Noncontrolling 821.4 779.3 interests Total shareholders’ 3,502.6 3,217.5 equity Total liabilities and $ 7,566.5 $ 7,089.7 shareholders’ equity

Nine Months Ended September 30, Cash flows from 2026 operating activities: (In Millions) 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 659.2 $ 556.0 (Income) loss from discontinued -14.5 1.8 operations, net of tax Adjustments to reconcile net income to net cash provided by operating activities— Depreciation and 273.4 241.5 amortization Loss on early 3.4 — extinguishment of debt Stock-based compensation 40.3 38.1 Deferred tax expense 1.6 3.2 Gain on investments -21.8 -6.1 Other, net 9.7 7.2 Change in assets and liabilities, net of acquisitions— Accounts receivable -89.5 -18.8 Other assets -20.8 -19.5 Accounts payable 43.5 -32.7 Accrued payroll 13.6 6.4 Accrued interest payable -5.7 -15.8 Other liabilities 46.1 70.8 Net cash provided by (used in) operating 19.2 -2.5 activities of discontinued operations Total adjustments 313.0 271.8 Net cash provided by operating 957.7 829.6 activities Cash flows from investing activities: Purchases of property, equipment, and -617.2 -507.1 intangible assets Proceeds from sale of restricted 83.2 160.0 investments Purchases of restricted -79.7 -165.9 investments Other, net -13.6 -12.2 Net cash used in -627.3 -525.2 investing activities Cash flows from financing activities: Proceeds from bond 598.8 — issuance Principal payments on debt, including -414.5 -113.2 pre-payments Borrowings on revolving 745.0 140.0 credit facility Payments on revolving -800.0 -80.0 credit facility Principal payments under finance lease -19.7 -17.7 obligations Debt amendment and -13.9 — issuance costs Repurchases of common stock, including -203.7 -81.7 fees and expenses Dividends paid on common -57.9 -52.1 stock Distributions paid to noncontrolling -141.8 -109.4 interests of consolidated affiliates Taxes paid on behalf of employees for -30.9 -19.9 shares withheld Other, net 5.5 0.2 Net cash used in -333.1 -333.8 financing activities Decrease in cash, cash equivalents, and -2.7 -29.4 restricted cash Cash, cash equivalents, and restricted 102.9 123.1 cash at beginning of period Cash, cash equivalents, and restricted $ 100.2 $ 93.7 cash at end of period

Reconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

Reconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

Reconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

Reconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

Reconciliation of Net Cash Provided by Operating Activities to Adjusted Free Cash Flow

For the three months ended September 30, 2026, net cash used in investing activities was $241.6 million and resulted primarily from capital expenditures. Net cash used in financing activities during the three months ended September 30, 2026 was $153.7 million and resulted primarily from repurchases of common stock, distributions paid to noncontrolling interests of consolidated affiliates, net debt payments, and cash dividends paid on common stock.

For the three months ended September 30, 2025, net cash used in investing activities was $201.3 million and resulted primarily from capital expenditures. Net cash used in financing activities during the three months ended September 30, 2025 was $113.2 million and resulted primarily from distributions paid to noncontrolling interests of consolidated affiliates, net debt payments, repurchases of common stock, and cash dividends paid on common stock.

For the nine months ended September 30, 2026 net cash used in investing activities was $627.3 million and resulted primarily from capital expenditures. Net cash used in financing activities during the nine months ended September 30, 2026 was $333.1 million and resulted primarily from repurchases of common stock, distributions paid to noncontrolling interests of consolidated affiliates, cash dividends paid on common stock, and taxes paid on behalf of employees for shares withheld partially offset by net debt borrowings.

For the nine months ended September 30, 2025, net cash used in investing activities was $525.2 million and resulted primarily from capital expenditures. Net cash used in financing activities during the nine months ended September 30, 2025 was $333.8 million and resulted primarily from distributions paid to noncontrolling interests of consolidated affiliates, repurchases of common stock, net debt payments, and cash dividends paid on common stock.

Statements contained in this press release and the supplemental information which are not historical facts, such as those relating to the business, strategy, outlook, growth targets and guidance considerations, dividend strategies, effective income tax rates, cost trends, legislative and regulatory developments or their impacts, financial guidance, ability to return value to shareholders, projected capital expenditures, acquisition opportunities, development projects, addressable market size, other balance sheet and cash flow plans, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, possible reductions or other changes in Medicaid reimbursement, including Medicaid directed and supplemental payment programs and Medicaid waiver programs, which may decrease our revenues and increase our provider tax expenses; infectious disease outbreak, including the speed, depth, geographic reach and duration of its spread, which could decrease our patient volumes and revenues and lead to staffing and supply shortages and associated cost increases; Encompass Health's infectious disease prevention and control efforts; the demand for Encompass Health’s services, including based on any downturns in the economy and consumer confidence in patient care; the price of Encompass Health's common stock as it affects Encompass Health's willingness and ability to repurchase shares and the financial and accounting effects of any repurchases; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving Encompass Health, including any matters related to yet undiscovered issues, if any, in acquired operations; Encompass Health's ability to attract and retain key management personnel; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's or its vendors' or partners’ information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information or inability to provide patient care because of system unavailability; Encompass Health's ability to successfully complete and integrate de novo developments, acquisitions, investments, and joint ventures consistent with its growth strategy; increases in Medicare audit activity, including increased use of sampling and extrapolation, resulting in additional unpaid reimbursement claims and an increase in the backlog of appealed claims denials; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; changes in the regulation of the healthcare industry at either or both of the federal and state levels, including as part of national healthcare reform and deficit reduction and Encompass Health's ability to adapt operations to those changes, including in connection with the CMS inpatient rehabilitation review choice demonstration project; competitive pressures in the healthcare industry and Encompass Health's response thereto; Encompass Health's ability to obtain and retain favorable arrangements with third-party payors; Encompass Health's ability to control costs, particularly labor and employee benefit costs, including group medical expenses; adverse effects resulting from coverage determinations made by Medicare Administrative Contractors regarding its Medicare reimbursement claims and lengthening delays in Encompass Health's ability to recover improperly denied claims through the administrative appeals process on a timely basis, including as part of the review choice demonstration; Encompass Health's ability to adapt to changes in the healthcare delivery system, including value-based purchasing such as the transforming episode accountability model and involvement in coordinated care initiatives or programs that may arise with its referral sources; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages, which may be worsened by infectious disease outbreaks, and the impact on Encompass Health's labor expenses from potential union activity, staffing shortages, and competitive compensation practices; general conditions in the economy and capital markets, including any instability or uncertainty related to trade war, armed conflict or an act of terrorism, governmental impasse over approval of the United States federal budget, an increase in the debt ceiling, or an international sovereign debt crisis; the increase in

the cost of, or the decrease in the availability of, construction materials and necessary supplies, including as a result of tariffs and import restrictions; the increase in the costs of defending and insuring against alleged professional liability claims, and Encompass Health's ability to predict the estimated costs related to such claims; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10‑K for the year ended December 31, 2025 and Form 10-Q for the quarters ended March 31, 2026, June 30, 2026, and September 30, 2026, when filed.

Full text with the tables
                                                                                
  Exhibit 99.1                                                                  
                                                                                
                                                        
  Media Contact                       October 28, 2026  
 ────────────────────────────────────────────────────── 
  Polly Manuel, 205 969-4532                            
  [email protected]                      
  Investor Relations Contact                            
  Mark Miller, 205 970-5860                             
  [email protected]                       
                                                        
                                                                                
            Encompass Health reports results for third quarter 2026             
                                                                                
                                                                                
                          Increases full-year guidance                          
                                                                                
BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner
and operator of inpatient rehabilitation hospitals in the United States, today
reported its results of operations for the third quarter ended September 30,
2026.

Summary results
                                                                                
         Q3                                                                     
         2026                                                                   
         (In                                                                    
         Mil…                                                                   
         Exc…                                                                   
         Per                                                                    
         Sha…                Q3                   Gro…                          
         Dat…                2025                 Dol…           Per…           
 ────────────────────────────────────────────────────────────────────────────── 
  Net                                                                           
  op…    $     1,6…          $     1,4…           $     132.0           8.9  %  
  re…                                                                           
  In…                                                                           
  fr…                                                                           
  co…                                                                           
  op…                                                                           
  at…                                                                           
  to           1.51                1.24                  0.27          21.8  %  
  En…                                                                           
  He…                                                                           
  per                                                                           
  di…                                                                           
  sh…                                                                           
  Ad…                                                                           
  ea…          1.52                1.23                  0.29          23.6  %  
  per                                                                           
  sh…                                                                           
  Ca…                                                                           
  fl…                                                                           
  pr…          362…                270…                  91.2          33.7  %  
  by                                                                            
  op…                                                                           
  ac…                                                                           
  Ad…          346…                300…                  46.5          15.5  %  
  EB…                                                                           
  Ad…                                                                           
  fr…          263…                174…                  89.2          51.2  %  
  ca…                                                                           
  fl…                                                                           
  (A…                                                                           
  Am…                                                                           
  Di…                69,…                65,8…                          5.7  %  
  Sa…                                                                           
  di…                                                                   3.0  %  
  gr…                                                                           
  Net                                                                           
  pa…                                                                           
  re…    $     22,…          $     21,…                                 4.0  %  
  per                                                                           
  di…                                                                           
                                                                                
See attached supplemental information for calculations of non-GAAP measures and
reconciliations to their most comparable GAAP measure.

“We are very pleased with our performance for the third quarter, with revenue
increasing 8.9% and Adjusted EBITDA growing 15.5%,” said Mark Tarr, President
and Chief Executive Officer. “During the first nine months of 2026, we opened
four hospitals totaling 189 beds and added 85 beds to existing hospitals,
reflecting our commitment to meeting the growing demand for high-quality
inpatient rehabilitation services. Our value proposition and disciplined
operating strategy continue to be validated, and we remain highly optimistic
about the long-term prospects of our business.”
     
  1  
     
                                                                                
  2026 Guidance                                                                 
                                                                                
The Company increased its full-year guidance as follows:
                                                                                
                                Full-Year 2026 Guidance                         
                                Previous Guidance             Updated Guidance  
                                -In Millions, Except Per                        
                                Share Data                                      
  Net operating revenue         $6,410 to $6,490              $6,450 to $6,500  
  Adjusted EBITDA               $1,365 to $1,395              $1,395 to $1,415  
  Adjusted earnings per                                                         
  share from                                                                    
  continuing operations         $6.02 to $6.25                $6.23 to $6.37    
  attributable to                                                               
  Encompass Health                                                              
                                                                                
For considerations regarding the Company’s 2026 guidance, see the supplemental
information posted on the Company’s website at
http://investor.encompasshealth.com. See also the “Other information” section
below for an explanation of why the Company does not provide guidance for
comparable GAAP measures for Adjusted EBITDA and adjusted earnings per share.
                                                                                
  Earnings conference call and webcast                                          
                                                                                
The Company will host an investor conference call at 10:00 a.m. Eastern Time on
Thursday, October 29, 2026 to discuss its results for the third quarter of 2026.
For reference during the call, the Company will post certain supplemental
information at http://investor.encompasshealth.com.

The conference call may be accessed by dialing 833 354-6854 and giving the
conference ID EHCQ326. International callers should dial 785 838-9343 and give
the same conference ID. Please call approximately ten minutes before the start
of the call to ensure you are connected. The conference call will also be
webcast live and will be available for on-line replay at
http://investor.encompasshealth.com by clicking on an available link.
                                                                                
  About Encompass Health                                                        
                                                                                
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient
rehabilitation hospitals in the United States. With a national footprint that
includes 179 hospitals in 39 states and Puerto Rico, the Company provides high-
quality, compassionate rehabilitative care for patients recovering from a major
injury or illness, using advanced technology and innovative treatments to
maximize recovery. Encompass Health is recognized by Newsweek as America’s Most
Awarded Leader in Inpatient Rehabilitation and is ranked among Fortune's World’s
Most Admired Companies™ 1 and Forbes’ America’s Best Companies. It is also
recognized by Becker’s Healthcare and Modern Healthcare as a top healthcare
employer. For more information, visit encompasshealth.com, or follow us on our
newsroom, X, Instagram and Facebook.

1 From Fortune. © 2026 Fortune Media IP Limited. All rights reserved. Fortune®
is a registered trademark and Fortune World’s Most Admired Companies™ is
trademark of Fortune Media IP Limited and are used under license. Fortune and
Fortune Media IP Limited are not affiliated with, and do not endorse products or
services of, Encompass Health.
     
  2  
     
                                                                                
  Other information                                                             
                                                                                
The information in this press release is summarized and should be read in
conjunction with the Company’s Quarterly Report on Form 10-Q for the quarter
ended September 30, 2026 (the “September 2026 Form 10-Q”), when filed, as well
as the Company’s Current Report on Form 8-K filed on October 28, 2026 (the “Q3
Earnings Form 8-K”), to which this press release is attached as Exhibit 99.1. In
addition, the Company will post supplemental information today on its website at
http://investor.encompasshealth.com for reference during its October 29, 2026
earnings call.

The financial data contained in the press release and supplemental information
include non-GAAP financial measures, including the Company’s adjusted earnings
per share, leverage ratio, Adjusted EBITDA, and adjusted free cash flow.
Reconciliations to their most comparable GAAP measure, except with regard to
non-GAAP guidance, are included below or in the Q3 Earnings Form 8-K. Readers
are encouraged to review the “Note Regarding Presentation of Non-GAAP Financial
Measures” included in the Q3 Earnings Form 8-K which provides further
explanation and disclosure regarding the Company’s use of these non-GAAP
financial measures.

Excluding net operating revenues, the Company does not provide guidance on a
GAAP basis because it is unable to predict, with reasonable certainty, the
future impact of items that are deemed to be outside the control of the Company
or otherwise not indicative of its ongoing operating performance. Such items
include government, class action, and related settlements; professional
fees—accounting, tax, and legal; mark-to-market adjustments for stock
appreciation rights; gains or losses related to hedging instruments; loss on
early extinguishment of debt; adjustments to its income tax provision (such as
valuation allowance adjustments and settlements of income tax claims); items
related to corporate and facility restructurings; and certain other items the
Company believes to be not indicative of its ongoing operations. These items
cannot be reasonably predicted and will depend on several factors, including
industry and market conditions, and could be material to the Company’s results
computed in accordance with GAAP.

However, the following reasonably estimable GAAP measures for 2026 would be
included in a reconciliation for Adjusted EBITDA if the other reconciling GAAP
measures could be reasonably predicted:

• Interest expense and amortization of debt discounts and fees - approximately
$130 million

• Amortization of debt-related items - approximately $10 million

The Q3 Earnings Form 8-K and, when filed, the September 2026 Form 10-Q can be
found on the Company’s website at http://investor.encompasshealth.com and the
SEC's website at www.sec.gov.
     
  3  
     
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                Condensed Consolidated Statements of Operations                 
                                                                                
                                  (Unaudited)                                   
                                                                                
        Thr…                                                                    
        Mon…                                                                    
        End…                                                                    
        Sep…                                                                    
        30,                                                                     
        2026                                                                    
        (In                                  Nine                               
        Mil…                                 Mon…                               
        Exc…                                 End…                               
        Per                                  Sep…                               
        Sha…                                 30,                                
        Dat…               20…               2026               20…             
 ────────────────────────────────────────────────────────────────────────────── 
  N…                                                                            
  o…    $     1,…          $    1,4…         $     4,…          $    4,3…       
  r…                                                                            
  O…                                                                            
  e…                                                                            
  S…                                                                            
  a…          84…               784…               2,…               2,3…       
  b…                                                                            
  O…                                                                            
  o…          24…               231…               74…               662…       
  e…                                                                            
  O…          15…               14.9               44…               44.5       
  c…                                                                            
  S…          65…               64.6               19…               189…       
  G…                                                                            
  a…          59…               56.1               18…               167…       
  a…                                                                            
  e…                                                                            
  D…                                                                            
  a…          95…               82.4               27…               241…       
  a…                                                                            
  T…                                                                            
  o…          1,…               1,2…               3,…               3,6…       
  e…                                                                            
  L…                                                                            
  on                                                                            
  e…            —                  —               3.4                  —       
  e…                                                                            
  of                                                                            
  d…                                                                            
  I…                                                                            
  e…                                                                            
  a…                                                                            
  a…                                                                            
  of          32…               30.8               96…               93.0       
  d…                                                                            
  d…                                                                            
  a…                                                                            
  f…                                                                            
  O…          -1…               -5.9               -2…               -15…       
  i…                                                                            
  E…                                                                            
  in                                                                            
  n…                                                                            
  i…          -0…               -1.2               -0…               -3.5       
  of                                                                            
  n…                                                                            
  a…                                                                            
  I…                                                                            
  f…                                                                            
  c…                                                                            
  o…          25…               219…               80…               695…       
  b…                                                                            
  i…                                                                            
  t…                                                                            
  e…                                                                            
  P…                                                                            
  f…                                                                            
  i…          53…               44.9               16…               137…       
  t…                                                                            
  e…                                                                            
  I…                                                                            
  f…          20…               175…               64…               557…       
  c…                                                                            
  o…                                                                            
  (…                                                                            
  i…                                                                            
  f…                                                                            
  d…          -0…               -0.4               14…               -1.8       
  o…                                                                            
  n…                                                                            
  of                                                                            
  t…                                                                            
  N…          20…               174…               65…               556…       
  i…                                                                            
  L…                                                                            
  N…                                                                            
  i…                                                                            
  a…          -5…               -48…               -1…               -13…       
  to                                                                            
  n…                                                                            
  i…                                                                            
  N…                                                                            
  i…                                                                            
  a…    $     14…          $    126…         $     49…          $    420…       
  to                                                                            
  E…                                                                            
  H…                                                                            
  W…                                                                            
  a…                                                                            
  c…                                                                            
  s…                                                                            
  o…                                                                            
  B…               98.3               10…               98.8               10…  
  D…               99.7               10…               100…               10…  
  E…                                                                            
  p…                                                                            
  c…                                                                            
  s…                                                                            
  B…                                                                            
  e…                                                                            
  p…                                                                            
  s…                                                                            
  a…                                                                            
  to                                                                            
  E…                                                                            
  H…                                                                            
  c…                                                                            
  s…                                                                            
  C…    $     1.…          $    1.26         $     4.…          $    4.19       
  o…                                                                            
  D…          -0…                  —               0.…               -0.…       
  o…                                                                            
  N…    $     1.…          $    1.26         $     5.…          $    4.17       
  i…                                                                            
  D…                                                                            
  e…                                                                            
  p…                                                                            
  s…                                                                            
  a…                                                                            
  to                                                                            
  E…                                                                            
  H…                                                                            
  c…                                                                            
  s…                                                                            
  C…    $     1.…          $    1.24         $     4.…          $    4.13       
  o…                                                                            
  D…          -0…                  —               0.…               -0.…       
  o…                                                                            
  N…    $     1.…          $    1.24         $     4.…          $    4.11       
  i…                                                                            
  A…                                                                            
  a…                                                                            
  to                                                                            
  E…                                                                            
  H…                                                                            
  c…                                                                            
  s…                                                                            
  I…                                                                            
  f…    $     15…          $    126…         $     48…          $    421…       
  c…                                                                            
  o…                                                                            
  (…                                                                            
  i…                                                                            
  f…                                                                            
  d…          -0…               -0.4               14…               -1.8       
  o…                                                                            
  n…                                                                            
  of                                                                            
  t…                                                                            
  N…                                                                            
  i…                                                                            
  a…    $     14…          $    126…         $     49…          $    420…       
  to                                                                            
  E…                                                                            
  H…                                                                            
                                                                                
     
  4  
     
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                     Condensed Consolidated Balance Sheets                      
                                                                                
                                  (Unaudited)                                   
                                                                                
                      September 30,                                             
                      2026                          December 31, 2025           
 ────────────────────────────────────────────────────────────────────────────── 
                      -In Millions                                              
  Assets                                                                        
  Current assets:                                                               
  Cash and cash       $                     76.2    $                     72.2  
  equivalents                                                                   
  Restricted cash                           24.0                          30.7  
  Accounts                                 712.0                         619.2  
  receivable                                                                    
  Other current                            200.8                         183.8  
  assets                                                                        
  Total current                          1,013.0                         905.9  
  assets                                                                        
  Property and                           4,477.6                       4,101.6  
  equipment, net                                                                
  Operating lease                                                               
  right-of-use                             194.5                         212.6  
  assets                                                                        
  Goodwill                               1,323.5                       1,317.6  
  Intangible                               301.5                         308.3  
  assets, net                                                                   
  Other long-term                          256.4                         243.7  
  assets                                                                        
  Total assets        $                  7,566.5    $                  7,089.7  
  Liabilities and                                                               
  Shareholders’                                                                 
  Equity                                                                        
  Current                                                                       
  liabilities:                                                                  
  Current portion                                                               
  of long-term        $                     47.8    $                     43.6  
  debt                                                                          
  Current                                                                       
  operating lease                           28.0                          26.5  
  liabilities                                                                   
  Accounts payable                         231.4                         178.2  
  Accrued expenses                                                              
  and other                                620.2                         588.1  
  current                                                                       
  liabilities                                                                   
  Total current                            927.4                         836.4  
  liabilities                                                                   
  Long-term debt,                                                               
  net of current                         2,551.3                       2,447.2  
  portion                                                                       
  Long-term                                                                     
  operating lease                          176.3                         196.6  
  liabilities                                                                   
  Deferred income                          127.5                         126.8  
  tax liabilities                                                               
  Other long-term                          222.8                         206.9  
  liabilities                                                                   
  Total                                  4,005.3                       3,813.9  
  liabilities                                                                   
  Commitments and                                                               
  contingencies                                                                 
  Redeemable                                                                    
  noncontrolling                            58.6                          58.3  
  interests                                                                     
  Shareholders’                                                                 
  equity:                                                                       
  Encompass Health                                                              
  shareholders’                          2,681.2                       2,438.2  
  equity                                                                        
  Noncontrolling                           821.4                         779.3  
  interests                                                                     
  Total                                                                         
  shareholders’                          3,502.6                       3,217.5  
  equity                                                                        
  Total                                                                         
  liabilities and     $                  7,566.5    $                  7,089.7  
  shareholders’                                                                 
  equity                                                                        
                                                                                
     
  5  
     
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                Condensed Consolidated Statements of Cash Flows                 
                                                                                
                                  (Unaudited)                                   
                                                                                
                              Nine Months Ended                                 
                              September 30,                                     
  Cash flows from             2026                                              
  operating activities:       (In Millions)                       2025          
 ────────────────────────────────────────────────────────────────────────────── 
  Net income                  $                          659.2    $      556.0  
  (Income) loss from                                                            
  discontinued                                           -14.5             1.8  
  operations, net of tax                                                        
  Adjustments to reconcile                                                      
  net income to                                                                 
  net cash provided by                                                          
  operating                                                                     
  activities—                                                                   
  Depreciation and                                       273.4           241.5  
  amortization                                                                  
  Loss on early                                            3.4               —  
  extinguishment of debt                                                        
  Stock-based compensation                                40.3            38.1  
  Deferred tax expense                                     1.6             3.2  
  Gain on investments                                    -21.8            -6.1  
  Other, net                                               9.7             7.2  
  Change in assets and                                                          
  liabilities, net of                                                           
  acquisitions—                                                                 
  Accounts receivable                                    -89.5           -18.8  
  Other assets                                           -20.8           -19.5  
  Accounts payable                                        43.5           -32.7  
  Accrued payroll                                         13.6             6.4  
  Accrued interest payable                                -5.7           -15.8  
  Other liabilities                                       46.1            70.8  
  Net cash provided by                                                          
  (used in) operating                                     19.2            -2.5  
  activities of                                                                 
  discontinued operations                                                       
  Total adjustments                                      313.0           271.8  
  Net cash provided by                                                          
  operating                                              957.7           829.6  
  activities                                                                    
  Cash flows from                                                               
  investing activities:                                                         
  Purchases of property,                                                        
  equipment, and                                        -617.2          -507.1  
  intangible assets                                                             
  Proceeds from sale of                                                         
  restricted                                              83.2           160.0  
  investments                                                                   
  Purchases of restricted                                -79.7          -165.9  
  investments                                                                   
  Other, net                                             -13.6           -12.2  
  Net cash used in                                      -627.3          -525.2  
  investing activities                                                          
  Cash flows from                                                               
  financing activities:                                                         
  Proceeds from bond                                     598.8               —  
  issuance                                                                      
  Principal payments on                                                         
  debt, including                                       -414.5          -113.2  
  pre-payments                                                                  
  Borrowings on revolving                                745.0           140.0  
  credit facility                                                               
  Payments on revolving                                 -800.0           -80.0  
  credit facility                                                               
  Principal payments under                                                      
  finance lease                                          -19.7           -17.7  
  obligations                                                                   
  Debt amendment and                                     -13.9               —  
  issuance costs                                                                
  Repurchases of common                                                         
  stock, including                                      -203.7           -81.7  
  fees and expenses                                                             
  Dividends paid on common                               -57.9           -52.1  
  stock                                                                         
  Distributions paid to                                                         
  noncontrolling                                        -141.8          -109.4  
  interests of                                                                  
  consolidated affiliates                                                       
  Taxes paid on behalf of                                                       
  employees for                                          -30.9           -19.9  
  shares withheld                                                               
  Other, net                                               5.5             0.2  
  Net cash used in                                      -333.1          -333.8  
  financing activities                                                          
  Decrease in cash, cash                                                        
  equivalents, and                                        -2.7           -29.4  
  restricted cash                                                               
  Cash, cash equivalents,                                                       
  and restricted                                         102.9           123.1  
  cash at beginning of                                                          
  period                                                                        
  Cash, cash equivalents,                                                       
  and restricted              $                          100.2    $       93.7  
  cash at end of period                                                         
                                                                                
     
  6  
     
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                            Supplemental Information                            
                                                                                
                                                                                
                               Earnings Per Share                               
                                                                                
                                                                                
        Thr…                                                                    
        Mon…                                                                    
        End…                                                                    
        Sep…                                                                    
        30,                                                                     
        2026                                                                    
        (In                                  Nine                               
        Mil…                                 Mon…                               
        Exc…                                 End…                               
        Per                                  Sep…                               
        Sha…                                 30,                                
        Dat…               20…               2026               20…             
 ────────────────────────────────────────────────────────────────────────────── 
  A…    $     34…          $    300…         $     1,…          $    932…       
  E…                                                                            
  D…                                                                            
  a…          -9…               -82…               -2…               -24…       
  a…                                                                            
  I…                                                                            
  e…                                                                            
  a…                                                                            
  a…                                                                            
  of          -3…               -30…               -9…               -93…       
  d…                                                                            
  d…                                                                            
  a…                                                                            
  f…                                                                            
  S…          -1…               -14…               -4…               -38…       
  c…                                                                            
  L…                                                                            
  on                                                                            
  d…                                                                            
  or          -0…               -1.9               -3…               -2.4       
  i…                                                                            
  of                                                                            
  a…                                                                            
              20…               170…               62…               557…       
  I…                                                                            
  n…                                                                            
  i…                                                                            
  of                                                                            
  o…                                                                            
  o…                                                                            
  p…                                                                            
  L…                                                                            
  on                                                                            
  e…            —                  —               -3…                  —       
  e…                                                                            
  of                                                                            
  d…                                                                            
  S…                                                                            
  r…                                                                            
  c…                                                                            
  i…          1.5                  —               1.5                  —       
  on                                                                            
  n…                                                                            
  i…                                                                            
  C…                                                                            
  in                                                                            
  f…                                                                            
  m…          -0…                1.1               1.9                2.1       
  v…                                                                            
  of                                                                            
  m…                                                                            
  s…                                                                            
  G…                                                                            
  on                                                                            
  s…            —                  —               17…                  —       
  of                                                                            
  G…                                                                            
  K…                                                                            
  P…          20…               171…               64…               559…       
  i…                                                                            
  I…                                                                            
  t…          -5…               -44…               -1…               -13…       
  e…                                                                            
  I…                                                                            
  f…    $     15…          $    126…         $     48…          $    421…       
  c…                                                                            
  o…                                                                            
  B…               98.3               10…               98.8               10…  
  s…                                                                            
  D…               99.7               10…               100…               10…  
  s…                                                                            
  B…                                                                            
  e…    $     1.…          $    1.26         $     4.…          $    4.19       
  p…                                                                            
  s…                                                                            
  D…                                                                            
  e…    $     1.…          $    1.24         $     4.…          $    4.13       
  p…                                                                            
  s…                                                                            
                                                                                
(1) Income from continuing operations attributable to Encompass Health
     
  7  
     
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                            Supplemental Information                            
                                                                                
                                                                                
                          Adjusted Earnings Per Share                           
                                                                                
                                                                                
                        Three                              Nine                 
                       Months                            Months                 
                        Ended                             Ended                 
                    September                         September                 
              2026        30,    2025           2026        30,    2025         
 ────────────────────────────────────────────────────────────────────────────── 
  Earnings                                                                      
  per                                                                           
  share,      $          1.51    $      1.24    $          4.83    $      4.13  
  as                                                                            
  reported                                                                      
  Adjustm…                                                                      
  net of                                                                        
  tax:                                                                          
  State                                                                         
  regulat…               0.01              —               0.01              —  
  change                                                                        
  impact                                                                        
  Income                                                                        
  tax                       —              —              -0.05          -0.12  
  adjustm…                                                                      
  Loss on                                                                       
  early                     —              —               0.02              —  
  extingu…                                                                      
  of debt                                                                       
  Change                                                                        
  in fair                                                                       
  market                    —          -0.01              -0.01          -0.01  
  value of                                                                      
  marketa…                                                                      
  securit…                                                                      
  Gain on                                                                       
  sale of                   —              —              -0.13              —  
  Gamma                                                                         
  Knife                                                                         
  Adjusted                                                                      
  earnings    $          1.52    $      1.23    $          4.67    $      3.99  
  per                                                                           
  share*                                                                        
                                                                                
* Adjusted EPS may not sum due to rounding.
     
  8  
     
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                            Supplemental Information                            
                                                                                
 Reconciliation of Net Cash Provided by Operating Activities to Adjusted EBITDA 
                                                                                
            Three                                                               
            Months                                                              
            Ended                            Nine                               
            Septem…                          Months                             
            30,                              Ended                              
            2026                             Septemb…                           
            (In                              30,                                
            Millio…           2025           2026                 2025          
 ────────────────────────────────────────────────────────────────────────────── 
  Net                                                                           
  cash                                                                          
  provi…    $        362.0    $     270.8    $           957.7    $      829.6  
  by                                                                            
  opera…                                                                        
  activ…                                                                        
  Inter…                                                                        
  expen…                                                                        
  and                                                                           
  amort…                                                                        
  of                  32.2           30.8                 96.8            93.0  
  debt                                                                          
  disco…                                                                        
  and                                                                           
  fees                                                                          
  (Loss)                                                                        
  gain                                                                          
  on                  -0.8            3.0                 21.8             6.2  
  inves…                                                                        
  exclu…                                                                        
  impai…                                                                        
  Equity                                                                        
  in net                                                                        
  income               0.1            1.2                  0.6             3.5  
  of                                                                            
  nonco…                                                                        
  affil…                                                                        
  Net                                                                           
  income                                                                        
  attri…                                                                        
  to                                                                            
  nonco…             -53.7          -48.1               -160.9          -135.9  
  inter…                                                                        
  in                                                                            
  conti…                                                                        
  opera…                                                                        
  Amort…                                                                        
  of                  -2.1           -2.4                 -6.7            -7.2  
  debt-…                                                                        
  items                                                                         
  Distr…                                                                        
  from                -0.1              —                 -0.3            -1.4  
  nonco…                                                                        
  affil…                                                                        
  Curre…                                                                        
  porti…                                                                        
  of                  57.2           47.0                161.8           134.3  
  income                                                                        
  tax                                                                           
  expen…                                                                        
  Change                                                                        
  in                                                                            
  assets             -48.1           -1.8                 12.8             9.6  
  and                                                                           
  liabi…                                                                        
  Cash                                                                          
  used                                                                          
  in                                                                            
  (prov…                                                                        
  by)                  1.1            0.6                -19.2             2.5  
  opera…                                                                        
  activ…                                                                        
  of                                                                            
  disco…                                                                        
  opera…                                                                        
  State                                                                         
  regul…                                                                        
  change                                                                        
  impact              -1.5              —                 -1.5               —  
  on                                                                            
  nonco…                                                                        
  inter…                                                                        
  Change                                                                        
  in                                                                            
  fair                                                                          
  market               0.3           -1.1                 -1.9            -2.1  
  value                                                                         
  of                                                                            
  marke…                                                                        
  secur…                                                                        
  Gain                                                                          
  on                                                                            
  sale                   —              —                -17.5               —  
  of                                                                            
  Gamma                                                                         
  Knife                                                                         
  Other                  —            0.1                 -0.1             0.2  
  Adjus…    $        346.6    $     300.1    $         1,043.4    $      932.3  
  EBITDA                                                                        
                                                                                
     
  9  
     
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                            Supplemental Information                            
                                                                                
 Reconciliation of Income from Continuing Operations Attributable to Encompass  
            Health per Diluted Share to Adjusted Earnings Per Share             
                                                                                
           For                                                                  
           the                                                                  
           Three                                                                
           Months                                                               
           Ended                                                                
           Septe…                                                               
           30,                                                                  
           2026                                                                 
 ────────────────────────────────────────────────────────────────────────────── 
                                  Adjus…                                        
                                                  Chan…                         
                                                  in                            
                                  State           Fair                          
           As                     Regul…          Mark…          As             
           Repor…                 Change          Value          Adjus…         
                                  Impact          of                            
                                                  Mark…                         
                                                  Secu…                         
           -In                                                                  
           Milli…                                                               
           Except                                                               
           Per                                                                  
           Share                                                                
           Amoun…                                                               
  Adju…    $       346.6          $          —    $         —    $       346.6  
  EBIT…                                                                         
  Depr…                                                                         
  and              -95.7                   2.9              —            -92.8  
  amor…                                                                         
  Inte…                                                                         
  expe…                                                                         
  and                                                                           
  amor…                                                                         
  of               -32.2                     —              —            -32.2  
  debt                                                                          
  disc…                                                                         
  and                                                                           
  fees                                                                          
  Stoc…            -15.0                     —              —            -15.0  
  comp…                                                                         
  Loss                                                                          
  on                                                                            
  disp…                                                                         
  or                -0.8                     —              —             -0.8  
  impa…                                                                         
  of                                                                            
  asse…                                                                         
  State                                                                         
  regu…                                                                         
  chan…                                                                         
  impa…              1.5                  -1.5              —                —  
  on                                                                            
  nonc…                                                                         
  inte…                                                                         
  Chan…                                                                         
  in                                                                            
  fair                                                                          
  mark…             -0.3                     —            0.3                —  
  value                                                                         
  of                                                                            
  mark…                                                                         
  secu…                                                                         
  Inco…                                                                         
  from                                                                          
  cont…                                                                         
  oper…            204.1                   1.4            0.3            205.8  
  befo…                                                                         
  inco…                                                                         
  tax                                                                           
  expe…                                                                         
  Prov…                                                                         
  for                                                                           
  inco…            -53.4                  -0.4           -0.1            -53.9  
  tax                                                                           
  expe…                                                                         
  Inco…                                                                         
  from                                                                          
  cont…                                                                         
  oper…    $       150.7          $        1.0    $       0.2    $       151.9  
  attr…                                                                         
  to                                                                            
  Enco…                                                                         
  Heal…                                                                         
  Dilu…                                                                         
  earn…                                                                         
  per                                                                           
  share    $        1.51          $       0.01    $         —    $        1.52  
  from                                                                          
  cont…                                                                         
  oper…                                                                         
  Dilu…                                                                         
  shar…                                                                         
  used                    99.7                                                  
  in                                                                            
  calc…                                                                         
                                                                                
* Reconciliation to GAAP provided on page 9

** Adjusted EPS may not sum across due to rounding.
      
  10  
      
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                            Supplemental Information                            
                                                                                
 Reconciliation of Income from Continuing Operations Attributable to Encompass  
            Health per Diluted Share to Adjusted Earnings Per Share             
                                                                                
          For                                                                   
          the                                                                   
          Three                                                                 
          Mont…                                                                 
          Ended                                                                 
          Sept…                                                                 
          30,                                                                   
          2025                                                                  
 ────────────────────────────────────────────────────────────────────────────── 
                                 Adjus…                                         
                                                 Chan…                          
                                                 in                             
                                 Income          Fair                           
          As                     Tax             Mark…           As             
          Repo…                  Adjus…          Value           Adjus…         
                                                 of                             
                                                 Mark…                          
                                                 Secu…                          
          -In                                                                   
          Mill…                                                                 
          Exce…                                                                 
          Per                                                                   
          Share                                                                 
          Amou…                                                                 
  Adj…    $      300.1           $          —    $          —    $       300.1  
  EBI…                                                                          
  Dep…                                                                          
  and            -82.4                      —               —            -82.4  
  amo…                                                                          
  Int…                                                                          
  exp…                                                                          
  and                                                                           
  amo…                                                                          
  of             -30.8                      —               —            -30.8  
  debt                                                                          
  dis…                                                                          
  and                                                                           
  fees                                                                          
  Sto…           -14.3                      —               —            -14.3  
  com…                                                                          
  Loss                                                                          
  on                                                                            
  dis…                                                                          
  or              -1.9                      —               —             -1.9  
  imp…                                                                          
  of                                                                            
  ass…                                                                          
  Cha…                                                                          
  in                                                                            
  fair                                                                          
  mar…             1.1                      —            -1.1                —  
  val…                                                                          
  of                                                                            
  mar…                                                                          
  sec…                                                                          
  Inc…                                                                          
  from                                                                          
  con…                                                                          
  ope…           171.8                      —            -1.1            170.7  
  bef…                                                                          
  inc…                                                                          
  tax                                                                           
  exp…                                                                          
  Pro…                                                                          
  for                                                                           
  inc…           -44.9                   -0.2             0.3            -44.8  
  tax                                                                           
  exp…                                                                          
  Inc…                                                                          
  from                                                                          
  con…                                                                          
  ope…    $      126.9           $       -0.2    $       -0.8    $       125.9  
  att…                                                                          
  to                                                                            
  Enc…                                                                          
  Hea…                                                                          
  Dil…                                                                          
  ear…                                                                          
  per                                                                           
  sha…    $       1.24           $          —    $      -0.01    $        1.23  
  from                                                                          
  con…                                                                          
  ope…                                                                          
  Dil…                                                                          
  sha…                                                                          
  used                  102.3                                                   
  in                                                                            
  cal…                                                                          
                                                                                
* Reconciliation to GAAP provided on page 9

** Adjusted EPS may not sum across due to rounding.
      
  11  
      
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                            Supplemental Information                            
                                                                                
 Reconciliation of Income from Continuing Operations Attributable to Encompass  
            Health per Diluted Share to Adjusted Earnings Per Share             
                                                                                
       F…                                                                       
       t…                                                                       
       N…                                                                       
       M…                                                                       
       E…                                                                       
       S…                                                                       
       3…                                                                       
       2…                                                                       
 ────────────────────────────────────────────────────────────────────────────── 
                     A…                                                         
                                                   C…                           
                               L…                  in        G…                 
                     S…        on        I…        F…        on                 
       As            R…        E…        T…        M…        S…        As       
       R…            C…        E…        A…        V…        of        A…       
                     I…        of                  of        G…                 
                               D…                  M…        K…                 
                                                   S…                           
       -…                                                                       
       M…                                                                       
       E…                                                                       
       P…                                                                       
       S…                                                                       
       A…                                                                       
  …    $   1…        $    —    $    —    $    —    $    —    $    —    $   1,…  
  …                                                                             
  …                                                                             
  …        -…            2…         —         —         —         —        -2…  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …        -…             —         —         —         —         —        -9…  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …        -…             —         —         —         —         —        -4…  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …        -…             —         —         —         —         —        -3…  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …        -…             —        3…         —         —         —          —  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …        1…            -…         —         —         —         —          —  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …        1…             —         —         —        -…         —          —  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …        1…             —         —         —         —        -…          —  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …        6…            1…        3…         —        -…        -…        63…  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …        -…            -…        -…        -…        0…        4…        -1…  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …    $   4…        $   1…    $   2…    $   -…    $   -…    $   -…    $   46…  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …    $   4…        $   0…    $   0…    $   -…    $   -…    $   -…    $   4.…  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …            1…                                                               
  …                                                                             
  …                                                                             
                                                                                
* Reconciliation to GAAP provided on page 9

** Adjusted EPS may not sum across due to rounding.
      
  12  
      
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                            Supplemental Information                            
                                                                                
 Reconciliation of Income from Continuing Operations Attributable to Encompass  
            Health per Diluted Share to Adjusted Earnings Per Share             
                                                                                
          For                                                                   
          the                                                                   
          Nine                                                                  
          Mont…                                                                 
          Ended                                                                 
          Sept…                                                                 
          30,                                                                   
          2025                                                                  
 ────────────────────────────────────────────────────────────────────────────── 
                                 Adju…                                          
                                                 Chan…                          
                                                 in                             
                                 Inco…           Fair                           
          As                     Tax             Mark…           As             
          Repo…                  Adju…           Value           Adjus…         
                                                 of                             
                                                 Mark…                          
                                                 Secu…                          
          -In                                                                   
          Mill…                                                                 
          Exce…                                                                 
          Per                                                                   
          Share                                                                 
          Amou…                                                                 
  Adj…    $      932.3           $          —    $          —    $       932.3  
  EBI…                                                                          
  Dep…                                                                          
  and            -241…                      —               —            -241…  
  amo…                                                                          
  Int…                                                                          
  exp…                                                                          
  and                                                                           
  amo…                                                                          
  of             -93.0                      —               —            -93.0  
  debt                                                                          
  dis…                                                                          
  and                                                                           
  fees                                                                          
  Sto…           -38.1                      —               —            -38.1  
  com…                                                                          
  Loss                                                                          
  on                                                                            
  dis…                                                                          
  or              -2.4                      —               —             -2.4  
  imp…                                                                          
  of                                                                            
  ass…                                                                          
  Cha…                                                                          
  in                                                                            
  fair                                                                          
  mar…             2.1                      —            -2.1                —  
  val…                                                                          
  of                                                                            
  mar…                                                                          
  sec…                                                                          
  Inc…                                                                          
  from                                                                          
  con…                                                                          
  ope…           559.4                      —            -2.1            557.3  
  bef…                                                                          
  inc…                                                                          
  tax                                                                           
  exp…                                                                          
  Pro…                                                                          
  for                                                                           
  inc…           -137…                  -11.8             0.6            -148…  
  tax                                                                           
  exp…                                                                          
  Inc…                                                                          
  from                                                                          
  con…                                                                          
  ope…    $      421.9           $      -11.8    $       -1.5    $       408.6  
  att…                                                                          
  to                                                                            
  Enc…                                                                          
  Hea…                                                                          
  Dil…                                                                          
  ear…                                                                          
  per                                                                           
  sha…    $       4.13           $      -0.12    $      -0.01    $        3.99  
  from                                                                          
  con…                                                                          
  ope…                                                                          
  Dil…                                                                          
  sha…                                                                          
  used                  102.3                                                   
  in                                                                            
  cal…                                                                          
                                                                                
* Reconciliation to GAAP provided on page 9

** Adjusted EPS may not sum across due to rounding.
      
  13  
      
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                            Supplemental Information                            
                                                                                
                                                                                
                Reconciliation of Net Income to Adjusted EBITDA                 
                                                                                
                                                                                
            Three                                                               
            Months                                                              
            Ended                            Nine                               
            Septem…                          Months                             
            30,                              Ended                              
            2026                             Septemb…                           
            (In                              30,                                
            Millio…           2025           2026                 2025          
 ────────────────────────────────────────────────────────────────────────────── 
  Net       $        203.6    $     174.6    $           659.2    $      556.0  
  income                                                                        
  Loss                                                                          
  (inco…                                                                        
  from                                                                          
  disco…                                                                        
  opera…                                                                        
  net of               0.8            0.4                -14.5             1.8  
  tax,                                                                          
  attri…                                                                        
  to                                                                            
  Encom…                                                                        
  Health                                                                        
  Net                                                                           
  income                                                                        
  attri…                                                                        
  to                                                                            
  nonco…             -53.7          -48.1               -160.9          -135.9  
  inter…                                                                        
  inclu…                                                                        
  in                                                                            
  conti…                                                                        
  opera…                                                                        
  Provi…                                                                        
  for                                                                           
  income              53.4           44.9                163.4           137.5  
  tax                                                                           
  expen…                                                                        
  Inter…                                                                        
  expen…                                                                        
  and                                                                           
  amort…                                                                        
  of                  32.2           30.8                 96.8            93.0  
  debt                                                                          
  disco…                                                                        
  and                                                                           
  fees                                                                          
  Depre…                                                                        
  and                 95.7           82.4                273.4           241.5  
  amort…                                                                        
  Loss                                                                          
  on                                                                            
  early                  —              —                  3.4               —  
  extin…                                                                        
  of                                                                            
  debt                                                                          
  Loss                                                                          
  on                                                                            
  dispo…                                                                        
  or                   0.8            1.9                  3.2             2.4  
  impai…                                                                        
  of                                                                            
  assets                                                                        
  Stock…              15.0           14.3                 40.3            38.1  
  compe…                                                                        
  State                                                                         
  regul…                                                                        
  change                                                                        
  impact              -1.5              —                 -1.5               —  
  on                                                                            
  nonco…                                                                        
  inter…                                                                        
  Change                                                                        
  in                                                                            
  fair                                                                          
  market               0.3           -1.1                 -1.9            -2.1  
  value                                                                         
  of                                                                            
  marke…                                                                        
  secur…                                                                        
  Gain                                                                          
  on                                                                            
  sale                   —              —                -17.5               —  
  of                                                                            
  Gamma                                                                         
  Knife                                                                         
  Adjus…    $        346.6    $     300.1    $         1,043.4    $      932.3  
  EBITDA                                                                        
                                                                                
      
  14  
      
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                            Supplemental Information                            
                                                                                
  Reconciliation of Net Cash Provided by Operating Activities to Adjusted Free  
                                   Cash Flow                                    
                                                                                
             Three                                                              
             Months                                                             
             Ended                            Nine                              
             Septem…                          Months                            
             30,                              Ended                             
             2026                             Septemb…                          
             (In                              30,                               
             Millio…           2025           2026                2025          
 ────────────────────────────────────────────────────────────────────────────── 
  Net                                                                           
  cash                                                                          
  provid…    $        362.0    $     270.8    $          957.7    $      829.6  
  by                                                                            
  operat…                                                                       
  activi…                                                                       
  Impact                                                                        
  of                    1.1            0.6               -19.2             2.5  
  discon…                                                                       
  operat…                                                                       
  Net                                                                           
  cash                                                                          
  provid…                                                                       
  by                                                                            
  operat…             363.1          271.4               938.5           832.1  
  activi…                                                                       
  of                                                                            
  contin…                                                                       
  operat…                                                                       
  Capital                                                                       
  expend…             -56.0          -61.4              -166.0          -140.5  
  for                                                                           
  mainte…                                                                       
  Distri…                                                                       
  paid to                                                                       
  noncon…                                                                       
  intere…             -43.7          -36.1              -141.8          -109.4  
  of                                                                            
  consol…                                                                       
  affili…                                                                       
  Items                                                                         
  not                                                                           
  indica…                                                                       
  of                                                                            
  ongoing                                                                       
  operat…                                                                       
  perfor…                                                                       
  Transa…                                                                       
  costs                                                                         
  and                     —            0.3                 3.5             0.3  
  related                                                                       
  liabil…                                                                       
  Adjust…                                                                       
  free       $        263.4    $     174.2    $          634.2    $      582.5  
  cash                                                                          
  flow                                                                          
                                                                                
For the three months ended September 30, 2026, net cash used in investing
activities was $241.6 million and resulted primarily from capital expenditures.
Net cash used in financing activities during the three months ended September
30, 2026 was $153.7 million and resulted primarily from repurchases of common
stock, distributions paid to noncontrolling interests of consolidated
affiliates, net debt payments, and cash dividends paid on common stock.

For the three months ended September 30, 2025, net cash used in investing
activities was $201.3 million and resulted primarily from capital expenditures.
Net cash used in financing activities during the three months ended September
30, 2025 was $113.2 million and resulted primarily from distributions paid to
noncontrolling interests of consolidated affiliates, net debt payments,
repurchases of common stock, and cash dividends paid on common stock.

For the nine months ended September 30, 2026 net cash used in investing
activities was $627.3 million and resulted primarily from capital expenditures.
Net cash used in financing activities during the nine months ended September 30,
2026 was $333.1 million and resulted primarily from repurchases of common stock,
distributions paid to noncontrolling interests of consolidated affiliates, cash
dividends paid on common stock, and taxes paid on behalf of employees for shares
withheld partially offset by net debt borrowings.

For the nine months ended September 30, 2025, net cash used in investing
activities was $525.2 million and resulted primarily from capital expenditures.
Net cash used in financing activities during the nine months ended September 30,
2025 was $333.8 million and resulted primarily from distributions paid to
noncontrolling interests of consolidated affiliates, repurchases of common
stock, net debt payments, and cash dividends paid on common stock.
      
  15  
      
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                           Forward-Looking Statements                           
                                                                                
Statements contained in this press release and the supplemental information
which are not historical facts, such as those relating to the business,
strategy, outlook, growth targets and guidance considerations, dividend
strategies, effective income tax rates, cost trends, legislative and regulatory
developments or their impacts, financial guidance, ability to return value to
shareholders, projected capital expenditures, acquisition opportunities,
development projects, addressable market size, other balance sheet and cash flow
plans, are forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. In addition, Encompass Health, through
its senior management, may from time to time make forward-looking public
statements concerning the matters described herein. All such estimates,
projections, and forward-looking information speak only as of the date hereof,
and Encompass Health undertakes no duty to publicly update or revise such
forward-looking information, whether as a result of new information, future
events, or otherwise. Such forward-looking statements are necessarily estimates
based upon current information and involve a number of risks and uncertainties.
Actual events or results may differ materially from those anticipated in these
forward-looking statements as a result of a variety of factors. While it is
impossible to identify all such factors, factors which could cause actual events
or results to differ materially from those estimated by Encompass Health
include, but are not limited to, possible reductions or other changes in
Medicaid reimbursement, including Medicaid directed and supplemental payment
programs and Medicaid waiver programs, which may decrease our revenues and
increase our provider tax expenses; infectious disease outbreak, including the
speed, depth, geographic reach and duration of its spread, which could decrease
our patient volumes and revenues and lead to staffing and supply shortages and
associated cost increases; Encompass Health's infectious disease prevention and
control efforts; the demand for Encompass Health’s services, including based on
any downturns in the economy and consumer confidence in patient care; the price
of Encompass Health's common stock as it affects Encompass Health's willingness
and ability to repurchase shares and the financial and accounting effects of any
repurchases; any adverse outcome of various lawsuits, claims, and legal or
regulatory proceedings involving Encompass Health, including any matters related
to yet undiscovered issues, if any, in acquired operations; Encompass Health's
ability to attract and retain key management personnel; potential disruptions,
breaches, or other incidents affecting the proper operation, availability, or
security of Encompass Health's or its vendors' or partners’ information systems,
including unauthorized access to or theft of patient, business associate, or
other sensitive information or inability to provide patient care because of
system unavailability; Encompass Health's ability to successfully complete and
integrate de novo developments, acquisitions, investments, and joint ventures
consistent with its growth strategy; increases in Medicare audit activity,
including increased use of sampling and extrapolation, resulting in additional
unpaid reimbursement claims and an increase in the backlog of appealed claims
denials; changes, delays in (including in connection with resolution of Medicare
payment reviews or appeals), or suspension of reimbursement for Encompass
Health's services by governmental or private payors; changes in the regulation
of the healthcare industry at either or both of the federal and state levels,
including as part of national healthcare reform and deficit reduction and
Encompass Health's ability to adapt operations to those changes, including in
connection with the CMS inpatient rehabilitation review choice demonstration
project; competitive pressures in the healthcare industry and Encompass Health's
response thereto; Encompass Health's ability to obtain and retain favorable
arrangements with third-party payors; Encompass Health's ability to control
costs, particularly labor and employee benefit costs, including group medical
expenses; adverse effects resulting from coverage determinations made by
Medicare Administrative Contractors regarding its Medicare reimbursement claims
and lengthening delays in Encompass Health's ability to recover improperly
denied claims through the administrative appeals process on a timely basis,
including as part of the review choice demonstration; Encompass Health's ability
to adapt to changes in the healthcare delivery system, including value-based
purchasing such as the transforming episode accountability model and involvement
in coordinated care initiatives or programs that may arise with its referral
sources; Encompass Health's ability to attract and retain nurses, therapists,
and other healthcare professionals in a highly competitive environment with
often severe staffing shortages, which may be worsened by infectious disease
outbreaks, and the impact on Encompass Health's labor expenses from potential
union activity, staffing shortages, and competitive compensation practices;
general conditions in the economy and capital markets, including any instability
or uncertainty related to trade war, armed conflict or an act of terrorism,
governmental impasse over approval of the United States federal budget, an
increase in the debt ceiling, or an international sovereign debt crisis; the
increase in
      
  16  
      
                                                                                
                 Encompass Health Corporation and Subsidiaries                  
                                                                                
                                                                                
                           Forward-Looking Statements                           
                                                                                
the cost of, or the decrease in the availability of, construction materials and
necessary supplies, including as a result of tariffs and import restrictions;
the increase in the costs of defending and insuring against alleged professional
liability claims, and Encompass Health's ability to predict the estimated costs
related to such claims; and other factors which may be identified from time to
time in Encompass Health's SEC filings and other public announcements, including
Encompass Health's Form 10‑K for the year ended December 31, 2025 and Form 10-Q
for the quarters ended March 31, 2026, June 30, 2026, and September 30, 2026,
when filed.
      
  17  
      

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/EHC/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.